
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
Smallpox vaccine revisited (diluted, too). CAM: Is it a national "threat"? Two down, two to go. Advice for kissin' cousins. Eye on Washington






